Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Increased frequency of CD4+ cells expressing CD161 in cancer patients.

Increased frequency of CD4+ cells expressing CD161 in cancer patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Increased frequency of CD4+ cells expressing CD161 in cancer patients. Abstract Text:

    eleni g iliopoulouEleni G Iliopoulou,michalis v karamouzisMichalis V Karamouzis,ioannis missitzisIoannis Missitzis,alexandros ardavanisAlexandros Ardavanis,nectaria n sotiriadouNectaria N Sotiriadou,constantin n baxevanisConstantin N Baxevanis,gerasimos rigatosGerasimos Rigatos,michael papamichailMichael Papamichail,sonia a perezSonia A Perez,

    PURPOSE: Although the function of natural killer receptors on T cells infiltrating tumors and their potential effect on antitumor immunity has been investigated, little is known about T cells expressing NKR-P1A (CD161) in cancer patients. In the present study, we examined T cells expressing CD161 in the peripheral blood, the tumor tissue and in malignant effusions of patients with several types of malignancies. EXPERIMENTAL DESIGN: Expression of CD161 in CD4(+) or CD8(+) (lacking CD56) T cells isolated from peripheral blood (n = 61), tumor specimens (n = 8), and malignant effusions (n = 37) of cancer patients was examined using four-color flow cytometry. Proliferative capacity and cytokine production of purified CD4(+)CD161(+)CD56(-) cells were studied after weak or strong stimulation, with or without costimulation, in the presence or absence of interleukin 2. The possible regulatory function of activated CD4(+)CD161(+)CD56(-) cells on T-cell alloresponses was also investigated. RESULTS: CD4(+) cells expressing CD161 were increased in cancer patients, compared with healthy individuals. This increase in the peripheral blood of cancer patients positively correlated with disease stage and was augmented at the tumor site. Phenotypic analysis revealed that CD4(+)CD161(+) cells are memory T cells, with low expression of activation markers. CD4(+)CD161(+) cells play an immunoregulatory role through cytokine production, because upon receiving costimulatory signals via CD28, they exert suppressive activity on autologous peripheral blood mononuclear cell alloresponses. CONCLUSIONS: CD4(+)CD161(+)CD56(-) cells represent a distinct memory T-cell population significantly increased in cancer patients. Depending on the type of signals provided by the tumor microenvironment, CD4(+)CD161(+) cells may regulate the immune response.

    Increased frequency of CD4+ cells expressing CD161 in cancer patients. Publishing Authors By Initials

    eg iliopoulouEG Iliopoulou,mv karamouzisMV Karamouzis,i missitzisI Missitzis,a ardavanisA Ardavanis,nn sotiriadouNN Sotiriadou,cn baxevanisCN Baxevanis,g rigatosG Rigatos,m papamichailM Papamichail,sa perezSA Perez,

    For similar biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research abstracts see: biochemical phenomena, metabolism, and nutrition: biochemical phenomena: structure-activity relationship research

    PUBMED ID PMID:

    MEDLINE DATE:

    Increased frequency of CD4+ cells expressing CD161 in cancer patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical cancer research : an official journal of

    VOLUME: 12

    Page Numbers: 6901-9

    Journal Abbreviation: Clin. Cancer Res.

    ISSN: 1078-0432

    DAY: 1

    MONTH: Dec

    YEAR: 2006

    Increased frequency of CD4+ cells expressing CD161 in cancer patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502500

    Increased frequency of CD4+ cells expressing CD161 in cancer patients. Keywords Mesh Terms:

    KEYWORDS: Structure-Activity Relationship

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Increased frequency of CD4+ cells expressing CD161 in cancer patients. Information

    Substance Name: CD161 antigen

    Registry Number: 145113-62-8

    Grant and Affiliation Information for Increased frequency of CD4+ cells expressing CD161 in cancer patients.

    AFFILIATION: Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Clin Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Increased frequency of CD4+ cells expressing CD161 in cancer patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News